Markets:

Overview

News

Currencies

International

Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

80.65 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 Next >

Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference

December 30, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces Amended Merger Agreement with STAAR Surgical

December 09, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds

November 11, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders

November 04, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

October 23, 2025

From STAAR Surgical Company

Via Business Wire

Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR

September 30, 2025

From Alcon Inc. Investors and STAAR Surgical Company

Via Business Wire

STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

September 16, 2025

From STAAR Surgical Company

Via Business Wire

Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS

September 16, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025

September 08, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon to Present at 2025 Baird Global Healthcare Conference

August 26, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical

August 19, 2025

From Alcon Inc. Investors

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WideOpenWest, Inc. (NYSE - WOW), BankFinancial Corporation (Nasdaq - BFIN), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)

August 12, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - CORZ)

August 05, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Alcon Agrees to Acquire STAAR Surgical

August 05, 2025

From Alcon Inc. Investors

Via Business Wire

Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity

July 22, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(NASDAQ:TEM) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

July 07, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease

May 28, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS

May 13, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces Results of 2025 Annual General Meeting

May 06, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS

April 25, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Publishes Agenda for 2025 Annual General Meeting

April 04, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

April 02, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

March 26, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

March 25, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Agrees to Acquire LENSAR, Inc.

March 24, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon to Host 2025 Capital Markets Day

March 13, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters

February 27, 2025

From Alcon Canada

Via Business Wire

Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation

February 25, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet

February 24, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension

February 19, 2025

From Alcon Inc. Investors

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.